The effect of acid-base disturbances on sodium/ proton (Na+ / H +) exchange has been examined in animal models; however, few data are available from human studies. To test the effect of metabolic acidosis on Na+/H+ exchange in man, as well as to examine the relationship between Na +/H+ exchange and cytosolic calcium ([Ca2+1;), we measured both variables in patients with decreased renal function with mild metabolic acidosis (pH 7.34±0.06), in normal control subjects (pH 7.41±0.02), and in subjects before (pH 7.40±0.01), and after (pH 7.26±0.04) ammonium chloride (NH4Cl) 15 g for 5 d. Lymphocytes and platelets were loaded with the cytosolic pH (pH;) indicator 2'-7'-bis(carboxyethyl)-5,6-carboxyfluorescein and acidified to pH -6.6 with propionic acid. To quantitate Na+/H+ exchange, dpHi/dt was determined at 1 min. [Ca2+ji was measured with fura-2. Na+/H+ exchange was significantly increased only in lymphocytes of patients with renal insufficiency. Neither intracellular pH (pH,) nor [Ca2+1i was different from controls. NH4CI resulted in a significant increase in Na+/H+ exchange in lymphocytes, but not in platelets of normal subjects. Values of pHi and [Ca2J1i in either cell type remained unaffected. Since metabolic acidosis influenced Na +/ H+ only in lymphocytes, but not in platelets, it is possible that protein synthesis may be involved in increasing Na+/H+ exchange. (J. Clin. Invest. 1993.92:858-865.)
Introduction
The Na+/H+ exchanger is an integral membrane protein that mediates a 1:1 electroneutral exchange ofextracellular Na+ for intracellular H + ions ( 1, 2). All vertebrate cells investigated so far contain such an exchange mechanism which regulates cytosolic pH (pHi) and cell volume, and which is activated by mitogenic stimuli and a variety of hormones ( 1, 2) . In renal epithelial cells, two types of Na+/H+ exchangers exist which are distinguished by their different sensitivities to amiloride and its analogues (3) . Here, Na+/H+ exchange is also involved in Na+ and HCO-absorption.
Hypertension and diabetes, which frequently occur concomitantly, are characterized by progressive vascular disease, the pathogenesis of which may involve Na+/H' exchange by as yet imperfectly defined mechanisms (4) . There is a high incidence ofboth, which results in, or contributes to, the development ofchronic renal failure (CRF).' Subtle disturbances in acid-base regulation have recently been described in patients prone to salt-sensitive, essential hypertension (5) . An enhanced Na' /H + exchange has been well documented in platelets, leukocytes, red blood cells, and skeletal muscle in essential hypertension, but little is known about the underlying mechanism (for a recent review see reference 6). It is conceivable that the phenomenon develops as a consequence of other hitherto unidentified hormonal or metabolic disturbances. Thus, the definition of factors that modulate Na+/H+ exchange activity in humans in vivo may also contribute to the understanding of this abnormality in disease states such as essential hypertension and diabetes.
While the effects of acid-base disturbances on Na+/H + exchange in renal tubular cells of experimental animals have been studied, few human data are available. We sought to characterize Na+/H+ exchange and pHi regulation in vivo in two states of metabolic acidosis in man. We first investigated chronic acidosis in patients with diminished renal function. Subsequently we investigated the effect of subacute, metabolic acidosis on Na+/H+ exchange in lymphocytes and platelets from normal individuals.
Methods
Subject groups and conditions. Due approval and informed consent were obtained from the normal subjects and patients with renal insufficiency before the investigations. The protocol was approved by the University ofErlangen committee for the protection ofhuman subjects according to the declaration of Helsinki.
Study I: chronic renal acidosis. Blood samples were obtained from 10 male patients with renal insufficiency, each of whom had a CiminoBrescia fistula placed in preparation for subsequent hemodialysis. These patients had a variety ofchronic renal diseases (glomerulonephritis, type II diabetes mellitus, hypertensive nephrosclerosis, and analgesic nephropathy), but none had type I diabetes mellitus. All were undergoing pharmacological treatment for hypertension. Venous blood specimens were also obtained from 10 healthy volunteer subjects as controls. Creatinine, Na', K+, Cl-, HCO-, Pco2, and pH were measured in serum or plasma as appropriate by automated methods.
Plasma renin activity and plasma aldosterone concentration were measured by radioimmunoassay (7).
Study II: induced metabolic acidosis in normal volunteers. Eight normal male volunteers were recruited to participate in a second protocol. Arterialized venous blood specimens (8) were obtained for the variables described above. These blood specimens all had an oxygen saturation of > 90%. Thereafter, the subjects ingested 30 500-mg NH4Cl capsules in six divided, five-capsule doses for a total of 5 d as described elsewhere (9) . On the morning of the fourth and fifth days, arterialized venous blood specimens were again obtained. On day 10 blood was again drawn for recovery observations. Preparation ofplatelet-rich plasma and isolation of lymphocytes. The blood was anticoagulated by the addition of 20% (vol/vol) ofacid citrate dextrose (85 mM trisodium citrate, 65 mM citric acid, and 11 mM glucose). Platelet-rich plasma was prepared by centrifugation of blood at 200 g for 15 min at room temperature. The upper two-thirds of the supernatant was used for preparation of either fura-2 or 2'-7'-bis(carboxyethyl)-5,6-carboxyfluorescein (BCECF)-loaded platelets. The remaining blood was resuspended 1:1 with Hepes-buffered RPMI 1640 medium, pH 7.4. Lymphocytes were prepared after centrifugation of blood on a Ficoll gradient ( 10) . Inspection of stained cell smears revealed that lymphocyte preparations were composed of 90% lymphocytes and 10% monocytes.
Measurement ofpHi. Cytosolic pH was determined using the fluorescent pH indicator BCECF. Pelleted platelets were resuspended in Hepes buffer consisting of 140 mM NaCl, 5 mM KCl, 5 mM KH2PO4, 1 mM MgSO4, 10 mM Hepes (free acid), and 5 mM glucose, pH 6.5 (at 37°C). 10 AtM BCECF-AM (final concentration; Molecular Probes, Inc., Eugene, OR) was added, and the cells were incubated for 30 min at 37°C. Thereafter, 1 ,uM PGI2 was added and the cells were washed twice in Hepes buffer, pH 6.5, by repeated centrifugation. The final platelet pellet was resuspended in Hepes buffer, pH 7.4, at a concentration of 5 X 109 cells/ml. 100-pi aliquots of these suspensions were transferred to 2 ml of Hepes buffer in a cuvette and prewarmed at 37°C. All measurements were conducted within 1 h after loading. During this time leakage of BCECF did not exceed 10% as assessed by comparison of fluorescence of platelets and corresponding supernatants and was, therefore, neglected.
Lymphocytes were incubated with 10 ,uM BCECF-AM for 30 min at 37°C in RPMI 1640 medium and washed twice in this medium by repeated centrifugation. Before prewarming to 37°C, aliquots of lymphocytes were briefly spun down in an Eppendorf centrifuge and then resuspended into Hepes buffer before being used for fluorescence measurements (final concentration I X 103 cells/,ul). This procedure efficiently removes extraneous dye. Leakage of dye during prewarming was < 10% and was therefore not corrected. The fluorescence of BCECF was recorded under constant stirring using a KONTRON SFM 24 spectrofluorimeter (Kontron, Dusseldorf, FRG) equipped with a thermostatted cuvette holder. Wavelengths for excitation and emission were set to 495 and 530 nm, respectively. Calibration of the BCECF signals in terms of pH1 was performed using the high K+/nigericin method ( 11).
Determination of Na+/H+ exchange activity. Na+/H+ exchange was activated by addition of various amounts of Na+-propionate or K+-propionate solution (final concentrations 10-50 mM) from a 1-M stock solution, pH 7.4, exactly as described recently ( 12) . Recovery of pHi in lymphocytes (Fig. 1 A) was inhibited by > 90% in the absence of extracellular sodium (Fig. 1 B) and by 95% at 10 ,uM of the specific inhibitor 5-(N-ethyl-N-isopropyl)-amiloride (EIPA; Fig. 1 C) . Both findings suggest that pHi recovery was almost exclusively mediated by Na+/ H + exchange. Osmotic activation ofthe antiport by 50 mM propionate appeared unlikely, as a challenge of cells by 50 mM NaCl failed to affect pHi (Fig. 1 D) . Identical observations were made in platelets (not shown).
Initial rates of EIPA-sensitive pHi recovery were calculated as described in detail recently (12) and are expressed as dpHi/min. The relationship between pHi and pHi recovery could best be described by a sigmoidal function as detailed earlier ( 12 Presentation ofdata. Unless stated otherwise, data are expressed as means±SD. Comparison between data was made by unpaired (patients and normal subjects) or paired (subjects before and after NH4Cl-induced metabolic acidosis) two-sided t tests. Differences were assumed to be significant at P < 0.05.
Results
Study I: chronic renal acidosis Clinical parameters and acid-base status ofpatients with renal insufficiency. In Table I are shown serum creatinine, Na', K+, and ClP, as well as plasma pH, Pco2, and HCO-of normal subjects and patients with CRF. Plasma pH, Pco2, and HCO3 values were significantly lower in the patients, while creatinine values were higher, compared with the normal subjects. Na+/H+ exchange and [Ca2+]i. In Fig. 2 Fig. 2 A) . The parameters of the fitted lines through the pooled data from all individuals yielded an apparent v., ofthe Na+/H+ exchanger of 0.053 dpHi/min in controls (Fig. 2 A) and a value of0.079 in patients (Fig. 2 B) . Apparent half-maximum activation occurred at pHi 6 .84 in controls and at pHi 6 .80 in patients, respectively. Hence, the increase in apparent v~n in the lymphocytes ofpatients was not accompanied by an alkaline shift in the Na+/H+ exchanger activation curve. In contrast, no such difference in vm,, was noticeable when platelets of controls (Fig. 2 C) and patients ( Fig. 2 D) were compared. The parameters of the fitted sigmoidal function yielded values for apparent v. of 0.086 and 0.096 dpHi/min in controls and patients, respectively. Thus, although the Na+/H+ exchanger appeared to be slightly enhanced also in platelets of patients with renal insufficiency, this difference was not statistically significant (see below). Apparent half-maximum activation ofthe antiport occurred at pHi 6 6. Platelets, on the other hand, displayed much higher pHi recovery rates than lymphocytes, perhaps due to their more favorable surface to volume ratio (Fig. 4 A) (Fig. 4 B) The effect of metabolic acidosis on platelet Na+/H+ exchange activity is displayed in Fig. 7 . In control (Fig. 7 A) apparent v.,, was calculated at 0.066 dpHi/min and this value did not significantly change on day 4 of NH4C1 treatment (0.076 dpHi/min; Fig. 7 B) . On NH4Cl-induced metabolic acidosis are shown in Fig. 8 
Discussion
Na+/H+ exchange in lymphocytes and platelets in CRF. We report here that lymphocyte but not platelet Na+/H+ exchange activity is significantly enhanced by a factor of -1.6 in cells from patients with CRF compared with those from controls (Figs. 2-4) . Thus we will first briefly discuss the mechanism(s) potentially mediating this behavior. The most trivial cause of an enhanced pHi recovery from acidification might be a reduction in the intracellular buffer capacity for H' in CRF. However, as identical amounts of propionate induced identical initial acidification in platelets and lymphocytes of controls and patients (Figs. 3 and 4) , this explanation can largely be ruled out. Furthermore, under our assay conditions (no HCO ) the buffer capacity is predominantly determined by the total cytosolic protein concentration. It appears unlikely that an almost twofold enhancement ofpHi recovery in lymphocytes is due to a corresponding 50% reduction in cytosolic protein concentration. In addition, other investigators have also determined un- Na+/IH exchange in lymphocytes during NH4Cl-induced metabolic acidosis. The main objective oftreating healthy subjects with NH4Cl was to answer the question whether the enhancement of Na+/H+ exchange observed in lymphocytes of CRF patients could be reproduced by simply imposing metabolic acidosis on these subjects. Thus, these otherwise healthy individuals were expected to display some ofthe abnormalities found in CRF patients, e.g., changes in plasma acid-base status and electrolyte composition and, potentially, similar acidosisrelated alterations in blood hormone composition, but were devoid of uremia-related changes in metabolism. In fact, acidbase status and electrolytes (except Cl -) were similar in CRF and during NH4CI-induced metabolic acidosis (cf . Tables I  and II) . The subjects noted some lassitude, but otherwise had no subjective side effects from NH4Cl, which at higher doses may cause quite profound effects primarily related to acidosis ( 18) . Body weight decreased by 2 kg, which we attributed to diuresis and natriuresis. Urine Na' excretion was not increased on day 5; however, it is likely that Na+ balance was reachieved by that time; the tl2 of Na' balance is 1.5 d (19) . We were surprised that blood pressure did not decrease. The sharp increase in renin and aldosterone values may have contributed to maintain blood pressure. The increased renin secretion may have been related to volume losses as reflected by body weight. The substantial amounts of Cl-ions delivered to the distal tubule would be expected to decrease rather than increase renin release. Kotchen et al. (20) have emphasized the role of Cldelivery to the thick ascending portion ofHenle's loop in signaling renal renin release. They found that increased Cl -delivery reduced renin release. A brisk kaliuresis ensued after NH4Cl administration. Serum K+ values were not changed, suggesting that cytosolic K+ concentrations may have decreased. Total body potassium depletion is known to increase renin release (21) . An increased urea synthesis and calciuresis are recognized features of NH4Cl administration ( 18) .
Na +/ H+ exchange activity was accelerated in lymphocytes during metabolic acidosis and it appears that this enhancement (Fig. 5 B) was strikingly similar to that observed in CRF patients (Fig. 2 B) . The reversibility of this enhancement also appears noteworthy and NaI/H+ exchange activity normalized in all subjects 5 d after the termination of NH4Cl treatment (Fig. 5 C) . Furthermore, it should be emphasized that NH4Cl ingestion enhanced the lymphocyte Na+/H' exchanger in all individuals examined, albeit to a different degree (Fig. 6) . In one individual pHi recovery was apparently higher before treatment with NH4Cl. However, we believe that this might reflect an experimental artifact rather than a true inverse behavior ofantiport activity. The results depicted in Fig. 6 In contrast, platelet Na+/H+ exchange activity was not significantly accelerated in metabolic acidosis in any of the individuals investigated. This observation was similar to that made in the CRF patients.
Taken together, Na+/H+ exchange is elevated in lymphocytes but not in platelets ofpatients with CRF, and the fact that this phenomenon could be reproduced in healthy volunteers after the ingestion of NH4C1 may suggest that in fact metabolic acidosis, but not other uremia-related abnormalities in CRF, mediate this enhancement.
The major issue is whether the enhancement of Na+/H+ exchange in blood cells is a direct result ofmetabolic acidosis in patients with renal failure and NH4Cl-treated volunteers, i.e., a direct consequence of reduced plasma pH (and, potentially, reduced pHi in vivo), or whether metabolic acidosis causes other hormonal changes that in turn activate the Na'/H+ exchanger. Some arguments may favor the notion that it is the fall in pHi that directly activates the Na+/H + exchanger, possibly by increasing the amount of exchanger protein in the plasma membrane. CRF is characterized by long-term metabolic acidosis. Krapf et al. (22) have shown that in rats metabolic but not respiratory acidosis induces an increase in antiport mRNA in kidney cortex. Moe et al. (23, 24) were able to confirm that mouse renal cortical tubule cells and an opossum kidney cell line responded to a 24-h in vitro metabolic acidosis with an almost twofold increase in Na+ /H+ exchange activity that was accompanied by a threefold increase in antiport mRNA. These results could be confirmed by feeding rats with a diet that induced metabolic acidosis. Fibroblasts, on the other hand, responded with a slight, albeit significant reduction in antiport activity in response to acidosis, which was paralleled by a reduction of antiport mRNA abundance (24) . Although details involving this behavior remain unexplained, the conclusion remains that acid preincubation may enhance antiport synthesis in some cells and tissues.
We are currently investigating whether or not NH4Cl-induced metabolic acidosis increases the steady-state concentration ofantiport mRNA in lymphocytes using quantitative polymerase chain reaction. Preliminary results indicate that antiport mRNA is in fact increased in metabolic acidosis by a factor of -1.5 above normal (Siffert, W., unpublished observations). This finding would also explain why metabolic acidosis enhances Na+/H+ exchanger only in nucleated lymphocytes but not in platelets, as these latter nonnucleated blood components are not capable of protein synthesis.
In summary, we present the first observations in man suggesting that Na+/H + exchange is important in the regulation of pHi under the condition of short-term and chronic metabolic acidosis. They suggest that pHi is well regulated even in the face of metabolic acidosis. The homeostatic adjustments in pHi regulation and the regulation of Na'/H+ exchange in other clinical acid-base disturbances and the effects of therapeutic interventions remain to be elucidated.
